- PRGF - ENDORET®
- Medical specialties
- BTI APNIA®
- Diagnosis
- Treatment

Autologous PRGF - ENDORET® technology provides biological solutions to accelerate the healing of musculoskeletal injuries and mitigate chronic pain with high predictability.


Clinically significant pain relief and reduction demonstrated across numerous pathologies.
As a strictly leucocyte-free technology, it prevents the unwanted release of matrix metalloproteinases, controls local inflammation, and contributes to improved clinical and functional outcomes.
The anti-fibrotic effect of PRGF - ENDORET® promotes tissue healing with correct fibre organisation.
Tissue regeneration while avoiding fibrosis minimises the risk of recurrence.
It drastically reduces tissue healing time in sports injuries.
Texto de ejemplo
Yes. PRGF - ENDORET® technology has validated protocols for application by means of intra- and perineural infiltrations. As it is a purely autologous product and strictly free of leukocytes, the inflammatory response and acute pain that these white blood cells would trigger on contact with peripheral nerve tissue are avoided. The controlled release of growth factors stimulates regeneration and minimises local fibrosis, making it a highly safe and effective option for accelerating axonal functional recovery and relieving pain in compression neuropathies (such as carpal tunnel syndrome).
PRGF - ENDORET® technology enables accelerated functional recovery, drastically reducing tissue healing time in sports injuries. For example, in acute muscle tears, it allows athletes to return to sport in half the time (11.4 days versus 21.3 days with conventional therapies), with no recurrences recorded at 6 months.
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
¡Gracias!